⌘K

Login Start Free

Home/Filings/4/0001209191-21-030745

4//SEC Filing

Vieser Jaime 4

Accession 0001209191-21-030745

CIK 0001107421other

View on SEC.gov Company Profile

Filed

May 5, 8:00 PM ET

Accepted

May 6, 7:26 PM ET

Size

12.3 KB

Accession

0001209191-21-030745

Insider Transaction Report

Form 4

Period: 2021-03-04

ZIOPHARM ONCOLOGY INCZIOP

Director

Transactions

Award
Stock Option (right to buy)
2021-03-04+31,250→ 31,250 total
Exercise: $4.31Exp: 2031-03-03→ Common Stock (31,250 underlying)
Award
Common Stock
2021-03-04+4,167→ 605,321 total
Award
Stock Option (right to buy)
2021-03-04+150,000→ 150,000 total
Exercise: $4.31Exp: 2031-03-03→ Common Stock (150,000 underlying)

Holdings

Common Stock
(indirect: By Children)
100,000
Common Stock
(indirect: By Children)
75,000
Common Stock
(indirect: By Children)
75,000
Common Stock
(indirect: By Children)
75,000

Footnotes (3)

[F1]The shares will vest on 5/19/2021.
[F2]1/3rd of the shares underlying this option will vest on 4/4/2021, 5/4/2021 and 5/19/2021.
[F3]1/36th of the shares underlying this option will vest in equal monthly installments commencing one month after 12/15/2020.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeother

Related Parties

1

filerCIK 0001846045

Filing Metadata

Form type: 4
Filed: May 5, 8:00 PM ET
Accepted: May 6, 7:26 PM ET
Size: 12.3 KB

View on SEC.gov